Our preliminary studies where we checked the combined effects of a monoclonal antibody against MUC1 used together with a novel dinuclear platinum complex (Pt12) showed high anti-proliferative properties and a strong cytotoxic activity in two breast cancer cell lines (MCF-7 and MDA-MB-231). Here, MUC1 is linked to breast carcinoma.